Backfunctionalized imidazolinium salts and NHC carbene-metal complexes

US10975038B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10975038-B2
Application numberUS-201916548472-A
CountryUS
Kind codeB2
Filing dateAug 22, 2019
Priority dateOct 9, 2014
Publication dateApr 13, 2021
Grant dateApr 13, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Backfunctionalized imidazolinium salts and methods of synthesizing the same and NHC carbene-metal complexes therefrom. For backfunctionalized imidazolinium salts of the formula: Wherein R 1 is selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 is selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; R 3 and R 4 are each an aliphatic group; and X is an anion; the method comprises cyclization of a halogenated acrylate with Hünig's base in a solvent.

First claim

Opening claim text (preview).

What is claimed is: 1. A backfunctionalized imidazolinium salt selected from the group of formulae consisting of: R 1 being selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 being selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; each of R 3 and R 4 being separately selected from the group consisting of a C 1 -C 20 alkyl group, C 1 -C 20 partially fluorinated alkyl group, an aryl group, an aryl group with para CF 3 functionality, an aryl group having C 1 -C 20 partially fluorinated alkyl groups or partially fluorinated alkoxy groups, and a C 1 -C 20 partially fluorinated aliphatic group, and a C 1 -C 20 aryl group; each of R 5 and R 6 being separately selected from the group consisting of a partially fluorinated alkyl group, a fluorinated aryl group, an aliphatic group, and an aryl group; and X is an anion. 2. The backfunctionalized imidazolinium salt of claim 1 , wherein X is a halogen anion. 3. The backfunctionalized imidazolinium salt of claim 1 , wherein R 1 is in a trans-configuration with respect to R 2 . 4. A free N-heterocyclic carbene synthesized by deprotonation of the backfunctionalized imidazolinium salt of claim 1 , wherein deprotonation includes reacting the backfunctionalized imidazolinium salt with silver oxide. 5. An N-heterocyclic carbene-metal complex comprising: a metal; and a first ligand comprising the free N-heterocyclic carbene of claim 4 , the first ligand being coordinated to the metal. 6. The N-heterocyclic carbene-metal complex of claim 5 , wherein the metal is selected from the group consisting of rhenium, ruthenium, osmium, rhodium, iridium, palladium, platinum, silver, and gold. 7. The N-heterocyclic carbene-metal complex of claim 5 , further comprising: a second ligand comprising another free N-heterocyclic carbene of claim 4 , the second ligand being coordinated to the metal. 8. The N-heterocyclic carbene-metal complex of claim 7 , further comprising: a third ligand selected from the group consisting of an acetylacetonate, alkoxy, alkyl, aryl, aryloxy, carbonyl, halide, imido, oxo, pyridine, trialkylphosphine, and triarylphosphine, the third ligand being coordinated to the metal. 9. The N-heterocyclic carbene-metal complex of claim 5 , further comprising: a second ligand selected from the group consisting of an acetylacetonate, alkoxy, alkyl, aryl, aryloxy, carbonyl, halide, imido, oxo, pyridine, trialkylphosphine, and triarylphosphine, the second ligand being coordinated to the metal. 10. A method of synthesizing the backfunctionalized imidazolinium salt of claim 1 , the method comprising: formamidine cyclization of a halogenated acrylate ester with Hünig's base in a solvent. 11. The method of claim 10 , wherein the solvent is selected from the group consisting of toluene and acetone. 12. The method of claim 10 , further comprising: introducing a base during the formamidine cyclization. 13. The method of claim 12 , wherein the base is selected from the group consisting of triethylamine, formamidine, and Hünig's base. 14. The method of claim 10 , further comprising: preparing halogenated, acrylate ester from an acrylate ester.

Assignees

Inventors

Classifications

  • Iridium compounds · CPC title

  • Ruthenium compounds · CPC title

  • C07D233/28Primary

    with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10975038B2 cover?
Backfunctionalized imidazolinium salts and methods of synthesizing the same and NHC carbene-metal complexes therefrom. For backfunctionalized imidazolinium salts of the formula: Wherein R 1 is selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 is se…
Who is the assignee on this patent?
Us Gov Air Force, Us Air Force
What technology area does this patent fall under?
Primary CPC classification C07D233/28. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).